MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy

PURPOSE: The role of adjuvant chemotherapy in patients with locally advanced bladder cancer still remains to be defined. We hypothesized that assessing the gene expression of the chemotherapy response modifiers multidrug resistance gene 1 (MDR1) and excision repair cross-complementing 1 (ERCC1) may...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hoffmann, Andreas-Claudius, Wild, Peter, Leicht, Christina, Bertz, Simone, Danenberg, Kathleen D, Danenberg, Peter V, Stöhr, Robert, Stöckle, Michael, Lehmann, Jan, Schuler, Martin, Hartmann, Arndt
Formato: Artigo
Idioma:Inglês
Publicado: Neoplasia Press Inc. 2010
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2915407/
https://ncbi.nlm.nih.gov/pubmed/20689757
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares